1. Extending Life in Duchenne Muscular Dystrophy: Implications for Appraisals of Cost-Effectiveness

   • Erik Landfeldt

   Commentary Open access 26 November 2018 Pages: 279 - 280

2. Use of Decision Modelling in Economic Evaluations of Diagnostic Tests: An Appraisal and Review of Health Technology Assessments in the UK

   • Yaling Yang
   • Lucy Abel
   • Bethany Shinkins

   Review Article Open access 14 December 2018 Pages: 281 - 291

   

3. Eribulin for Treating Locally Advanced or Metastatic Breast Cancer After One Chemotherapy Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

   • Nigel Fleeman
   • Adrian Bagust
   • Nicky Thorp

   Review Article Open access 11 February 2019 Pages: 293 - 302

4. Evolution of Average European Medicine Prices: Implications for the Methodology of External Price Referencing

   • Sabine Vogler
   • Peter Schneider
   • Nina Zimmermann

   Original Research Article Open access 05 February 2019 Pages: 303 - 309

   

5. The Worth of a Quality-Adjusted Life-Year in Patients with Diabetes: An Investigation Study using a Willingness-to-Pay Method

   • Najme Moradi
   • Arash Rashidian
   • Leila Zarei

   Original Research Article Open access 08 January 2019 Pages: 311 - 319

6. Economic Evaluation of Nivolumab Plus Ipilimumab Combination as First-Line Treatment for Patients with Advanced Melanoma in Canada

   • Peter L. Quon
   • Ying Xiao
   • Amir Abbas Tahami Monfared

   Original Research Article Open access 08 January 2019 Pages: 321 - 331

   

7. Economic Impact and Clinical Outcomes of Omalizumab Add-On Therapy for Patients with Severe Persistent Asthma: A Real-World Study

   • Luis Manuel Entrenas Costa
   • Francisco Casas-Maldonado
   • Juan José Martín Villasclaras

   Original Research Article Open access 25 January 2019 Pages: 333 - 342

   

8. Estimated Versus Observed Expenditure Associated with Medicines Recommended by the All Wales Medicines Strategy Group

   • Stuart Keeping
   • Paul N. Deslandes
   • Philip A. Routledge

   Original Research Article Open access 17 January 2019 Pages: 343 - 350

   

9. The Role of Real-World Evidence in UK Reimbursement: Case Study of Lenalidomide in Myelodysplastic Syndrome Deletion 5q

   • Dawn Lee
   • Nic Brereton
   • Austin Kulasekararaj

   Original Research Article Open access 14 December 2018 Pages: 351 - 358

   

10. Remote Monitoring of Patient-Reported Outcomes in Ulcerative Colitis: A Prospective Real-World Pilot Study

    • Shaji Sebastian
    • Jenna Roberts
    • Sumesh Kachroo

    Original Research Article Open access 21 March 2019 Pages: 359 - 365

    

11. Associations between Health-Related Quality of Life and Self-Reported Emergency Room Department Visits and Inpatient Hospitalizations: Insights from a Secondary Data Analysis of Patients with Light-Chain (AL) Amyloidosis

    • Kristen L. McCausland
    • Avery A. Rizio
    • Tiffany P. Quock

    Original Research Article Open access 22 February 2019 Pages: 367 - 375

    

12. Cost Effectiveness of Avelumab for Metastatic Merkel Cell Carcinoma

    • Ash Bullement
    • Paul Nathan
    • Murtuza Bharmal

    Original Research Article Open access 24 January 2019 Pages: 377 - 390

    

13. Cost of Treatment of Valvular Heart Disease at a Tertiary Hospital in North India: Policy Implications

    • Shankar Prinja
    • Yashpaul Sharma
    • Rajesh Kumar

    Original Research Article Open access 19 February 2019 Pages: 391 - 402

    

14. A Review of Issues Affecting the Efficiency of Decision Making in the NICE Single Technology Appraisal Process

    • M. J. Walton
    • J. O’Connor
    • R. Hodgson

    Original Research Article Open access 08 January 2019 Pages: 403 - 410

    

15. Costs of Acute Headache Medication Use and Productivity Losses Among Patients with Migraine: Insights from Three Randomized Controlled Trials

    • Joshua K. Porter
    • Gian Luca Di Tanna
    • Guillermo Villa

    Short Communication Open access 30 October 2018 Pages: 411 - 417

    

16. All-Male Panels and Gender Diversity of Issue Panels and Plenary Sessions at ISPOR Europe

    • Jacoline C. Bouvy
    • Michelle Mujoomdar

    Research Letter Open access 22 July 2019 Pages: 419 - 422

    

17. All Male Panels and Other Diversity Considerations for ISPOR

    • Nancy J. Devlin

    Letter to the Editor Open access 22 July 2019 Pages: 423 - 426

    

18. Correction to: Conducting a Time Trade-Off Study Alongside a Clinical Trial: A Case Study and Recommendations

    • Jing Shen
    • Sarah Hill
    • Rob Pickard

    Correction Open access 23 May 2019 Pages: 427 - 427